RHYTHM PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$2.80M, a 141.23% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $487.00K, a 84.80% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $2.71M, a 52.55% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$6.38M, a 6123.58% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $6.33M, a 14.54% increase from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $5.52M.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.88M.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$498.00K, a 114.91% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.32M 10-Q · filed 2026-08-04 | $390.00K derived: sum of 3 quarters · filed 2026-08-04 | -$6.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $487.00K 10-Q · filed 2026-05-05 | $3.19M derived: sum of 2 quarters · filed 2026-05-05 | -$3.19M derived: sum of 3 quarters · filed 2026-05-05 | $3.61M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.68M derived: sum of 2 quarters · filed 2026-02-26 | $3.12M derived: sum of 3 quarters · filed 2026-08-04 | $6.33M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $416.00K derived: sum of 2 quarters · filed 2026-08-04 | $3.62M 10-Q · filed 2025-11-04 | $9.32M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.01M 10-Q · filed 2026-08-04 | $15.71M derived: sum of 3 quarters · filed 2026-08-04 | $15.82M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-05 | $8.91M derived: sum of 2 quarters · filed 2026-05-05 | $9.02M derived: sum of 3 quarters · filed 2026-05-05 | $6.31M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.81M derived: sum of 2 quarters · filed 2026-02-26 | $3.10M derived: sum of 3 quarters · filed 2026-02-26 | $5.52M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.60M derived: sum of 2 quarters · filed 2025-11-04 | -$181.00K 10-Q · filed 2025-11-04 | -$5.42M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$287.00K 10-Q · filed 2025-08-05 | -$5.53M derived: sum of 3 quarters · filed 2026-02-26 | -$1.62M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $2.42M 10-Q · filed 2025-05-07 | -$2.82M derived: sum of 2 quarters · filed 2026-02-26 | $1.08M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.34M derived: sum of 2 quarters · filed 2026-02-26 | -$721.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.88M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $4.52M derived: sum of 2 quarters · filed 2024-11-06 | $2.37M 10-Q · filed 2024-11-06 | $4.67M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.54M 10-Q · filed 2024-08-06 | $2.86M 10-Q · filed 2023-08-01 | $768.00K derived: sum of 3 quarters · filed 2025-02-28 | $667.00K derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | -$2.15M 10-Q · filed 2024-05-07 | $186.00K 10-Q · filed 2023-05-02 | $153.00K derived: sum of 2 quarters · filed 2025-02-28 | $52.00K derived: sum of 3 quarters · filed 2025-02-28 | -$1.70M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.21M derived: sum of 2 quarters · filed 2025-02-28 | $452.00K derived: sum of 3 quarters · filed 2025-02-28 | -$498.00K 10-K · filed 2025-02-28 | $1.82M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.86M derived: sum of 2 quarters · filed 2023-11-08 | -$2.81M 10-Q · filed 2023-11-08 | $1.07M 10-Q · filed 2022-11-08 | $2.12M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$2.71M 10-Q · filed 2023-08-01 | $580.00K 10-Q · filed 2022-08-03 | $2.23M derived: sum of 3 quarters · filed 2024-02-29 | -$740.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$950.00K 10-Q · filed 2023-05-02 | $3.98M derived: sum of 2 quarters · filed 2024-02-29 | $1.01M derived: sum of 3 quarters · filed 2024-02-29 | $4.04M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.97M derived: sum of 2 quarters · filed 2024-02-29 | $4.99M derived: sum of 3 quarters · filed 2024-02-29 | $3.34M 10-K · filed 2024-02-29 | $4.60M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $60.00K derived: sum of 2 quarters · filed 2022-11-08 | -$1.59M 10-Q · filed 2022-11-08 | -$1.05M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.37M 10-Q · filed 2022-08-03 | $1.92M derived: sum of 3 quarters · filed 2023-03-01 | $471.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$1.65M 10-Q · filed 2022-05-03 | -$1.11M derived: sum of 2 quarters · filed 2023-03-01 | -$2.55M derived: sum of 3 quarters · filed 2023-03-01 | -$3.05M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$903.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.40M derived: sum of 3 quarters · filed 2023-03-01 | -$551.00K 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$1.94M derived: sum of 2 quarters · filed 2021-11-02 | -$1.09M 10-Q · filed 2021-11-02 | $694.00K derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | -$495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $352.00K 10-Q · filed 2021-08-03 | $2.14M derived: sum of 3 quarters · filed 2021-08-03 | $2.68M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $847.00K 10-Q · filed 2021-05-03 | $2.63M derived: sum of 2 quarters · filed 2021-05-03 | $3.18M derived: sum of 3 quarters · filed 2021-05-03 | $3.90M derived: sum of 4 quarters · filed 2021-05-03 | ||||
| 2019-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.33M derived: sum of 2 quarters · filed 2021-03-01 | $3.06M derived: sum of 3 quarters · filed 2021-03-01 | $6.38M 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.27M derived: sum of 2 quarters · filed 2020-11-02 | $4.59M 10-Q · filed 2020-11-02 | $8.12M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $727.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $4.05M 10-Q · filed 2020-08-03 | $7.57M derived: sum of 3 quarters · filed 2021-03-01 | $9.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $3.32M 10-Q · filed 2020-05-04 | $6.85M derived: sum of 2 quarters · filed 2021-03-01 | $8.77M derived: sum of 3 quarters · filed 2021-03-01 | $10.19M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.45M derived: sum of 2 quarters · filed 2021-03-01 | $6.87M derived: sum of 3 quarters · filed 2021-03-01 | $6.29M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $3.34M derived: sum of 2 quarters · filed 2019-11-01 | $2.76M 10-Q · filed 2019-11-01 | $3.68M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $833.00K 10-Q · filed 2019-07-29 | $1.75M derived: sum of 3 quarters · filed 2020-03-02 | $2.65M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$581.00K 10-Q · filed 2019-05-03 | $336.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.24M derived: sum of 3 quarters · filed 2020-03-02 | $1.00M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.82M derived: sum of 2 quarters · filed 2020-03-02 | $1.58M derived: sum of 3 quarters · filed 2020-03-02 | $1.89M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $667.00K derived: sum of 2 quarters · filed 2018-11-09 | $972.00K 10-Q · filed 2018-11-09 | $659.00K derived: sum of 4 quarters · filed 2019-03-08 | ||||
| 2017-06-30 | -$237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $68.00K 10-Q · filed 2018-08-08 | -$245.00K derived: sum of 3 quarters · filed 2019-03-08 | |||||
| 2017-03-31 | $305.00K 10-Q · filed 2018-05-14 | -$8.00K derived: sum of 2 quarters · filed 2019-03-08 | ||||||
| 2016-12-31 | -$313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$41.00K 10-K · filed 2019-03-08 | ||||||
| 2016-09-30 | $272.00K 10-Q · filed 2017-11-14 | |||||||
| 2015-12-31 | $581.00K 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |